Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Unrelated Male Donors Versus Sibling Parous Female Donors: Impact on Transplant-Related Outcomes

Anita J Kumar, MDMS, Soyoung Kim, PhD, Michael Hemmer, MS, Mukta Arora, MD, Steve Spellman, MBS, Joseph A. Pidala, MD, Daniel Couriel, MD MS, Amin M. Alousi, MD, Alison W Loren, MD MS

Blood (2016) 128 (22): 70.

https://doi.org/10.1182/blood.V128.22.70.70

Published: 2016

Journal Articles

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Muna Qayed, MD MSc, John Horan, MD MPH, Stephen R. Spellman, MBS, Mukta Arora, MD, Tao Wang, PhD, Michael Hemmer, MS, Joseph A Pidala, MD, PhD, Daniel Couriel, MD MS, Amin M. Alousi, MD

Blood (2016) 128 (22): 2228.

https://doi.org/10.1182/blood.V128.22.2228.2228

Published: 2016

Journal Articles

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

Mark T. Vander Lugt, M.D., Thomas M. Braun, Ph.D., Samir Hanash, M.D., Ph.D., James L.M. Ferrara, MD, DSc, Jerome Ritz, MD, Vincent T. Ho, MD, Joseph H. Antin, MD, Qing Zhang, Alice Chin, Aurelie Gomez, MD, Andrew C. Harris, M.D., John E. Levine, M.D., M.S., Sung W. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, M.D., Ph.D

Blood (2012) 120 (21): 466.

https://doi.org/10.1182/blood.V120.21.466.466

Published: 2012

Journal Articles

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

Gregory A. Yanik, John M. Magenau, Shin Mineishi, Attaphol Pawarode, Keith Alangaden, Edward M. Peres, Steven Goldstein, John E. Levine, Sung Choi, Carrie L Kitko, Moshe Talpaz, MD, Daniel Couriel

Blood (2012) 120 (21): 3119.

https://doi.org/10.1182/blood.V120.21.3119.3119

Published: 2012

Journal Articles

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

Andrzej J. Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole, Sundar Jagannath, Ammar Al-Zoubi, Tara Anderson, Brian Nordgren, Kristen Detweiler-Short, Keith Stockerl-Goldstein, Asra Ahmed, Terri Jobkar, Diane E. Durecki, Kathryn McDonnell, Melissa Mietzel, Daniel Couriel, Mark Kaminski, Ravi Vij

Blood (2012) 120 (9): 1801–1809.

https://doi.org/10.1182/blood-2012-04-422683

Published: 2012

Includes: Supplemental data

Journal Articles

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Mark T. Vander Lugt, M.D., Thomas Braun, PhD, James L.M. Ferrara, MD, DSc, Samir Hanash, M.D., Ph.D., John E. Levine, MD, MS, Chee-Hong Wang, Qing Zhang, Alice Chin, Andrew C. Harris, M.D., Sung W.J. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): 152.

https://doi.org/10.1182/blood.V118.21.152.152

Published: 2011

Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Blood (2011) 118 (21): 631.

https://doi.org/10.1182/blood.V118.21.631.631

Published: 2011

Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Blood (2010) 116 (21): 675.

https://doi.org/10.1182/blood.V116.21.675.675

Published: 2010

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients (pts) with Advanced Chronic Myeloid Leukemia (CML) Post Imatinib Failure.

Elias Jabbour, Marcos De Lima, Leandro de Padua Silva, Sergio Giralt, Jorge Cortes, Muzaffar Qazilbash, Gabriela Rondon, Stefan Ciurea, Roy Jones, Yago Nieto, Martin Korbling, Daniel Couriel, Hagop Kantarjian, Richard Champlin

Blood (2008) 112 (11): 979.

https://doi.org/10.1182/blood.V112.11.979.979

Published: 2008

Journal Articles

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Blood (2008) 111 (12): 5530–5536.

https://doi.org/10.1182/blood-2008-01-136242

Published: 2008

Journal Articles

Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.

Constantine S. Tam, MBBS, Celina Ledesma, BS, Martin Korbling, MD, Luis E. Fayad, MD, Michael Wang, MD, Amin Alousi, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Gabriela Rondon, MD, Sergio A. Giralt, MD, Paolo Anderlini, MD, Uday Popat, MD, Daniel Couriel, MD, Barbara Pro, MD, Barry Samuels, MD, Frederick Hagemeister, MD, Richard E. Champlin, MD, Issa F. Khouri, MD

Blood (2007) 110 (11): 484.

https://doi.org/10.1182/blood.V110.11.484.484

Published: 2007

Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Martin Korbling, MD, Chitra Hosing, MD, Luis Fayad, MD, Ming S. Lee, MD, Felipe Samaniego, MD, Barry I. Samuels, MD, Daniel Couriel, MD, Fredrick Hagemeister, MD, Peter McLaughlin, MD, Richard E. Champlin, MD

Blood (2007) 110 (11): 485.

https://doi.org/10.1182/blood.V110.11.485.485

Published: 2007

Journal Articles

A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants.

Poliana Patah, Rima Saliba, Marcelo Fernandez-Vina, Pedro Cano, Susana Pesoa, Gabriela Rondon, Borje Andersson, Sergio Giralt, Partow Kebriaei, Chitra Hosing, Paolo Anderlini, Daniel Couriel, Amin Alousi, Leandro Padua, Carlos Ramos, Richard Champlin, Marcos de Lima

Blood (2007) 110 (11): 3051.

https://doi.org/10.1182/blood.V110.11.3051.3051

Published: 2007

Journal Articles

Graft-Versus-Host Disease (GVHD) in Cord Blood Transplantation (CBT): Risk Factors, Clinical Manifestations and Outcomes.

Daniel Couriel, MD, Poliana Patah, MD, Rima Saliba, PhD, Lawrence Cooper, MD, Laura Worth, MD, Dimitrios Petropoulos, MD, Leandro Depadua, MD, Weiqing Zhang, Sergio Giralt, MD, Richard Champlin, MD, Elizabeth J. Shpall, MD, Marcos de Lima, MD

Blood (2007) 110 (11): 2977.

https://doi.org/10.1182/blood.V110.11.2977.2977

Published: 2007

Journal Articles

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

Partow Kebriaei, Michelle A. Detry, Sergio Giralt, Antonio Carrasco-Yalan, Athanasios Anagnostopoulos, Daniel Couriel, Issa F. Khouri, Paolo Anderlini, Chitra Hosing, Amin Alousi, Richard E. Champlin, Marcos de Lima

Blood (2007) 110 (9): 3456–3462.

https://doi.org/10.1182/blood-2007-04-085969

Published: 2007

Journal Articles

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, Nancy Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, Bruce R. Blazar

Blood (2006) 109 (6): 2657–2662.

https://doi.org/10.1182/blood-2006-08-013995

Published: 2006

Journal Articles

Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.

Paolo Anderlini, Rima M. Saliba, Sandra Acholonu, Sergio A. Giralt, Issa F. Khouri, Borje Andersson, Marcos De Lima, Chitra Hosing, Daniel Couriel, Richard E. Champlin

Blood (2006) 108 (11): 3115.

https://doi.org/10.1182/blood.V108.11.3115.3115

Published: 2006

Journal Articles

HLA-DP Mismatches Increase the Risk of Acute GVHD after Unrelated Donor Hematopoietic Transplantation (UDT).

Marcos de Lima, Simrit Parmar, Ping Liu, Poliana A. Patah, Pedro Cano, Elizabeth J. Shpall, Chitra Hosing, Daniel Couriel, Paolo Anderlini, Sergio Giralt, Borje S. Andersson, Partow Kebriaei, Gabriela Rondon, Richard Champlin, Marcelo Fernandez-Vina

Blood (2006) 108 (11): 3125.

https://doi.org/10.1182/blood.V108.11.3125.3125

Published: 2006

Journal Articles

Donor-Recipient Host-Versus-Graft (HVG) HLA Mismatches and Outcome of Cord Blood Transplants (CBT).

Marcos de Lima, Poliana A. Patah, Rima Saliba, Daniel Couriel, Kawah Chan, Laura Worth, Sergio Giralt, Partow Kebriae, Issa Khouri, Laurence Cooper, Marcelo Fernandez-Vina, Pedro Cano, Demetrios Petropoulos, John McMannis, Chitra Hosing, Gabriela Rondon, Krishna V. Komanduri, Richard E. Champlin, Elizabeth J. Shpall

Blood (2006) 108 (11): 436.

https://doi.org/10.1182/blood.V108.11.436.436

Published: 2006

Journal Articles

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

Partow Kebriaei, MD, Michelle Detry, PhD, Antonio Carrasco-Yalan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Issa Khouri, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Amin Alousi, MD, Sergio Giralt, MD, Richard Champlin, MD, Marcos de Lima, MD

Blood (2006) 108 (11): 2898.

https://doi.org/10.1182/blood.V108.11.2898.2898

Published: 2006

NARROW

Unrelated Male Donors Versus Sibling Parous Female Donors: Impact on Transplant-Related Outcomes

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients (pts) with Advanced Chronic Myeloid Leukemia (CML) Post Imatinib Failure.

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.

Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.

A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants.

Graft-Versus-Host Disease (GVHD) in Cord Blood Transplantation (CBT): Risk Factors, Clinical Manifestations and Outcomes.

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.

HLA-DP Mismatches Increase the Risk of Acute GVHD after Unrelated Donor Hematopoietic Transplantation (UDT).

Donor-Recipient Host-Versus-Graft (HVG) HLA Mismatches and Outcome of Cord Blood Transplants (CBT).

Long-Term Follow-Up of Allogeneic Stem Cell Transplantation (SCT) with Reduced Intensity Conditioning (RIC) for Patients (pts) with Chronic Myeloid Leukemia (CML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only